Collectively, functional decline of the SIRT1–PGC-1α–NRF1/2–TFAM axis constitutes a central event underlying mitochondrial biogenic failure in sarcopenia and represents a promising therapeutic target. This evidence concerns the gene NRF1 and sarcopenia.